ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.

Andere Sprachen Zhejiang Hisoar Pharmaceutical Co., Ltd.

Aktien

002099

CNE000001PY2

002099

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 14.05.2024			% 5 Tage	% 1. Jan.
6,36 ^CNY	+0,79 %		-3,05 %	-11,54 %

28.04.	Zhejiang Hisoar Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
02.02.	Zhejiang Hisoar Pharmaceutical Co., Ltd. (SZSE:002099) kündigt einen Aktienrückkauf im Wert von CNY 30 Millionen an.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28.04.
Hisoar Pharma's Unit Passes German Health Regulator's Inspection	18.04.
Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	01.04.
Zhejiang Hisoar Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares.	02.02.
Hisoar Pharma Chairman Plans Up to 20 Million Yuan Investment	02.02.
Zhejiang Hisoar Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	02.02.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30.10.23
Zhejiang Hisoar Pharma Passes Good Manufacturing Practice Compliance Inspection	22.09.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29.08.23
Zhejiang Hisoar Pharma Registers New Drug For Diabetes Patients	11.07.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 24 May 2023	19.05.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Approves the Profit Distribution Proposal for 2022	16.05.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for 2022	25.04.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24.04.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24.04.23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Elects Tao Hong as Non-Independent Director; and Yu Yongping, Qian Jianmin and Liang Chao as Independent Directors	01.12.22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30.10.22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22.08.22
Hainan Visum Pharmaceutical Co Ltd announced that it has received $15 million in funding from Zhejiang Hisoar Pharmaceutical Co., Ltd.	29.06.22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 25 May 2022	18.05.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zhejiang Hisoar Pharmaceutical Co., Ltd.

Aktien

002099

CNE000001PY2

002099

Andere Sprachen

Filter